Acasti Pharma Inc. (ACST) is priced at $0.57 after the most recent trading session. At the very opening of the session, the stock price was $0.45 and reached a high price of $0.6123, prior to closing the session it reached the value of $0.45. The stock touched a low price of $0.4485.
Recently in News on December 23, 2020, Acasti Pharma Unaware of Any Material Change. At the request of IIROC, Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST) wishes to confirm that the Company’s management and Board of Directors are unaware of any material change in the Company’s operations that would account for the recent increase in market activity. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Acasti Pharma Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.6123 on 01/08/21, with the lowest value was $0.3200 for the same time period, recorded on 01/04/21.
Acasti Pharma Inc. (ACST) full year performance was -74.67%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Acasti Pharma Inc. shares are logging -75.32% during the 52-week period from high price, and 233.33% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.17 and $2.31.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 140140003 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Acasti Pharma Inc. (ACST) recorded performance in the market was 75.38%, having the revenues showcasing 174.76% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 55.23M, as it employees total of 32 workers.
Analysts verdict on Acasti Pharma Inc. (ACST)
During the last month, 0 analysts gave the Acasti Pharma Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.2909, with a change in the price was noted -0.1445. In a similar fashion, Acasti Pharma Inc. posted a movement of -20.22% for the period of last 100 days, recording 20,519,639 in trading volumes.
Acasti Pharma Inc. (ACST): Technical Analysis
Raw Stochastic average of Acasti Pharma Inc. in the period of last 50 days is set at 90.41%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 88.51%. In the last 20 days, the company’s Stochastic %K was 70.45% and its Stochastic %D was recorded 67.88%.
Let’s take a glance in the erstwhile performances of Acasti Pharma Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 75.38%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -19.54%, alongside a downfall of -74.67% for the period of the last 12 months. The shares increased approximately by 75.38% in the 7-day charts and went down by 93.35% in the period of the last 30 days. Common stock shares were driven by 174.76% during last recorded quarter.